Assesment of Quality of Care in Gynaecological Oncology during a national centralization process

Assesment of Quality of Care in Gynaecological Oncology
during a national centralization process

(Highly Specialized Medicine)

ESGO - Swiss-AGO cooperation

Study information

The aim of the study is to provide a collection of health-related routine data of patients treated for ovarian cancer to examine the quality of care during the process of a government-driven centralization (highly specialized medicine, HSM) in Switzerland.

Currently, advanced ovarian cancers in Switzerland are treated across various hospitals, without requiring a gynecological oncology specialization. To enhance care quality, the Swiss Government Health Organization (GDK) and Swiss-AGO have initiated a centralization process, allowing only specialized centers meeting specific criteria to perform ovarian cancer care. Centralization is expected to begin in Q3 of 2024, with quality control led by Prof. Heinzelmann-Schwarz.

Study Synopsis

Prof Viola Heinzelmann Schwarz

Switzerland

Prof Nicole Concin

Austria

Prof Ane Gerda Eriksson

Norway

Prof Christoph Grimm

Austria

Participating centres

Universitätsspital Basel
Prof. Dr. med. Viola Heinzelmann-Schwarz

Inselspital Bern
Prof. Dr. med. Michel Müller

Réseau hospitalier neuchâtelois RHNe
Dr. med. Yves Brünisholz

SpitalSTS AG - Spital Thun
Dr. med. Christoph Ackermann

Gynäkologisches Tumorzentrum Thurgau, Kantonsspital Münsterlingen / Frauenfeld
Prof. Dr. med. Mathias Fehr

HFR hôpital fribourgeois - Hôpital cantonal, Bertigny
Dr. med. Benedetta Guani

Stadtspital Zürich Triemli
Dr. med. Natalie Gabriel

Spital Schwyz
Dr. med. Georgios Gatopoulos

Kantonsspital Baden
Prof. Dr. med. Martin Heubner

 

Kantonsspital St. Gallen
Prof. Dr. med. René Hornung

Hôpital du Valais, CHVR - Hôpital de Sion
Prof. Dr. med. Daniela Emanuela Huber

GZO, Spital Wetzikon
Dr. med. Alexandra Johanna Kochanowski

Centre hospitalier universitaire vaudois
Prof. Dr. med. Patrice Mathevet

Kantonsspital Winterthur
Dr. med. Gesine Meili Anton

Hôpitaux universitaires de Genève
Dr. med. Manuela Undurraga Malinoverno

Frauenzentrum Bern, Lindenhofgruppe
Prof. Dr. med. Ralf Rothmund

Kantonsspital Aarau
PD Dr. med. Dimitri Sarlos

Spital Grabs
Prof. Dr. med. Seraina Schmid

Universitätsspital Zürich
Prof. Dr. med. Isabell Witzel

EOC - Ospedale Regionale di Lugano
Prof. Dr. med. Andrea Papadia

St. Claraspital Basel
Prof. Rosanna Zanetti Dällenbach

Kantonsspital Graubünden
Dr. med. Peter Martin Fehr

Hirslanden-Klinik St. Anna
Prof. Dr. med. Andreas Günther

Luzerner Kantonsspital
Prof. Dr. med. Christine E. Brambs

Patient information

As part of the project, ESGO and SWISS-AGO collect and register routine data from women treated for advanced ovarian cancer at centres participating in this study. By keeping strict personal data protection measures, ESGO and SWISS-AGO ensure transparent data processing and provide clear information to patients in compliance with all respective data protection regulations in place, in particular, EU Regulation 2016/679 (GDPR).

In view of the scientific research purposes, public interest in the field of public health, and ESGO and SWISS-AGO‘s legitimate interests in carrying out research projects, processing of personal data in the context of research projects based on the routinely collected data requires the collection of patients' individual consent. This is ensured by a given consent to the hospital’s general consent, a registry-specific consent (see file for download below) or the consent for further use of data from the MATAO trial. General information about this study is publicly available at the centres participating in this study and on the ESGO website.

General Patient Information Sheet

Any patient, however, may refuse to allow the inclusion of their data in research projects based on the collected data. If you are a patient who objects to participation in research studies, please contact your treating gynaecologist at your hospital. You can also object by filling in this objection form and emailing it to database@esgo.org. In such cases, your personal data will not be included in research projects.

REDCap: Data upload

REDCap account creation

ESGO will create individual REDCap access for each centre.

Please reach out to us at database@esgo.org and provide the names and email addresses of all individuals responsible for data entry or otherwise requiring access from your centre.

Entry of centre-level data

Please refer to the instructions provided below for guidance on how to enter centre-level data.

PDF instructions how to enter centre-level data

Video tutorial how to enter centre-level data:

Entry of patient-level data

There are two ways to enter patient data.

  1. Case by case (one patient’s data at a time): the data of each patient is directly entered into the REDCap system, one patient at a time (similar to an eCRF).
PDF instructions how to enter individual patient data case by case

Video tutorial how to enter individual patient data case by case:

  1. Spreadsheet (bulk data for many patients uploaded at once): This option is only recommended for high-volume centres (e.g. ESGO centres of excellence for advanced ovarian cancer surgery). All participating centres have been supplied with a spread sheet file template containing all clinical parameters that are collected in the frame of this research project. The completed file (in the format of a CSV file) can be directly uploaded to the REDCap system so that all patient data from the file are uploaded together.
PDF instructions how to bulk enter patient data

Data entry - Recording Missing Data

PDF instructions on recording missing data

If you encounter any issues or problems, please contact ESGO via database@esgo.org.

We are here to support you!